Your browser doesn't support javascript.
loading
Enhancing PSMA PET/CT imaging of prostate cancer: investigating the impact of multiple time point evaluation, diuretic administration, cribriform pattern, and intraductal carcinoma.
Guner, Levent A; Unal, Kemal; Beylergil, Volkan; Tuna, Mustafa Bilal; Saglican, Yesim; Vardareli, Erkan; Kural, Ali Riza.
Afiliación
  • Guner LA; Department of Nuclear Medicine, Acibadem University, Acibadem Maslak Hospital, Sariyer, Istanbul, Turkey. levent.guner@acibadem.com.
  • Unal K; Department of Nuclear Medicine, Acibadem University, Acibadem Maslak Hospital, Sariyer, Istanbul, Turkey.
  • Beylergil V; Department of Radiology, Division of Abdominal Imaging, Columbia University Irving Medical Center, New York, USA.
  • Tuna MB; Department of Urology, Acibadem Maslak Hospital, Istanbul, Turkey.
  • Saglican Y; Department of Pathology, Acibadem University, Istanbul, Turkey.
  • Vardareli E; Department of Nuclear Medicine, Acibadem University, Acibadem Maslak Hospital, Sariyer, Istanbul, Turkey.
  • Kural AR; Department of Urology, Acibadem University, Istanbul, Turkey.
Ann Nucl Med ; 37(11): 618-628, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37783903
OBJECTIVE: Our objective was to correlate staging PSMA PET imaging parameters to final histopathology. Second objective was to assess the performance of standard versus delayed PSMA PET to detect primary prostate tumor. METHODS: Thirty-one patients (mean age, 61.4 ± 8.2) who underwent radical prostatectomy and preoperative staging PSMA PET scans were included in the study. After defining dominant lesion in pathology, correlations with PET images were performed. Additionally, two physicians blind to clinical and pathological information retrospectively reviewed staging Ga-68 PSMA PET scans with standard and delayed imaging. RESULTS: Dominant lesion SUV's increased with time 8.2(± 4.5), 10(± 7.1), and 10.2(± 7.8) at 1, 2, and 3 h (P = .03 T1-T3). WHO Grade group 3 had highest SUV (group 3 11.9 ± 5.6 vs. group 2 7.9 ± 1.5, p = .02). Addition of cribriform pattern on intraductal component was associated with higher SUV's (11 ± 2.9 vs. 6.5 ± 2.1, p = .01) and higher Gleason four ratios (64 ± 9% vs. 37 ± 17%, p = .01). Intraductal carcinoma was associated with larger tumors (6.3 ± 2.3 cm3 vs. 2.6 ± 1.7 cm3, p < .001). Physician sensitivities ranged from 61 to 81%. Excluding Gleason 3 + 3 lesions and small lesions (< 1 cm3), sensitivities increased to 80-100%. Differences of sensitivity between different time points were not significant. Combined evaluation of all time points did not increase sensitivity. CONCLUSIONS: Cribriform pattern correlates with higher Gleason 4 ratios and SUVs in PSMA PET. Intraductal carcinoma is associated with larger tumors but not higher Gleason 4 ratios and SUVs. Multiple late imaging times did not enhance tumor detection and may pose tolerability issues for some patients.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Carcinoma Intraductal no Infiltrante Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Ann Nucl Med Asunto de la revista: MEDICINA NUCLEAR Año: 2023 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Carcinoma Intraductal no Infiltrante Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Ann Nucl Med Asunto de la revista: MEDICINA NUCLEAR Año: 2023 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Japón